<SEC-DOCUMENT>0001157523-23-000103.txt : 20230126
<SEC-HEADER>0001157523-23-000103.hdr.sgml : 20230126
<ACCEPTANCE-DATETIME>20230126163243
ACCESSION NUMBER:		0001157523-23-000103
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20230126
FILED AS OF DATE:		20230126
DATE AS OF CHANGE:		20230126

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		23558157

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a53291907.htm
<DESCRIPTION>ICON PLC 6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: business wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">FORM 6-K</div>
    <div style="text-align: center;">&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month of January 2023</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;">ICON plc</div>
    <div style="text-align: center;">(Translation of registrant's name into English)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zec5ae04161cd4e8ea14d2e3afc873af0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F __<font style="font-weight: bold;">X</font>___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F ______</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="3">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">
            <div>&#160;</div>
          </td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">&#160;<u>EXHIBIT LIST</u></div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z1a32c69eabb149e1b5bbd0235e9c93b4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div><u>Exhibit</u></div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div><a href="a53291907ex99_1.htm">99.1</a></div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div><a href="a53291907ex99_1.htm">ICON plc Schedules Fourth Quarter 2022
                Earnings Conference Call</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
      thereunto duly authorized.</div>
    <div>&#160;</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z37bdc3d50ab941c4b092d12c7d4bb000" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div>Date: January 26, 2023</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>&#160;</div>
          </td>
          <td style="width: 25%; vertical-align: middle;">
            <div>Brendan Brennan</div>
            <div>Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a53291907ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: business wire
         Document created using EDGARfilings PROfile 8.4.0.0
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <div>
    <div class="bw-release">
      <div class="bw-release">
        <h1 style="text-align: center; list-style-position: inside;FONT-SIZE: 14pt;"> <b>ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call</b> </h1>
        <div class="bw-release-body">
          <div class="bw-release-table-js bw-release-story">
            <p>DUBLIN--(BUSINESS WIRE)--January 26, 2023--<u>ICON</u><u> plc</u> <b>(NASDAQ: ICLR),</b> a world-leading healthcare intelligence and clinical research organisation, today announced that it will
              release its financial results for the fourth quarter 2022 after the market closes on Wednesday, February 22, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, February 23,
              2023 at 8:00am ET. </p>
            <p> Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under &#8220;Events&#8221;. A webcast replay of the conference call will be available approximately one hour following
              the conclusion of the call. </p>
            <p> <b>About ICON plc</b> </p>
            <p> ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government
              and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as at
              September 30, 2022. For further information about ICON, visit: www.iconplc.com. </p>
            <p> This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not
              guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties
              and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new
              offices and offering of new services, the integration of new business mergers and acquisitions, the impact of COVID-19 on our business, as well as other economic and global market conditions and other risks and uncertainties detailed from
              time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment
              decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation
              to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports
              filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov. </p>
            <p> Source: ICON plc </p>
            <p> <b>ICON/ICLR-G</b> </p>
          </div>
          <div class="bw-release-contact">
            <h2 style="FONT-SIZE: 14pt;">Contacts</h2>
            <p> Kate Haven <br>
              Vice President Investor Relations <br>
              +1888 381 7923 </p>
          </div>
        </div>
      </div>
    </div>
    <font style="font-weight: bold;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
